Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

November 2, 2004 Approval Letter - Influenza Virus Vaccine Live, Intranasal

Public Health Service
Food and Drug Administration
1401 Rockville Pike
Rockville, MD 20852-1448

November 2, 2004

Submission Tracking Number (STN): BL 125020/43

Peter Patriarca, M.D.
MedImmune Vaccines, Inc.
One MedImmune Way
Gaithersburg, MD 20878

Dear Dr. Patriarca:

We have received your October 20, 2004, Supplement to your Biologics License Application (BLA) for Influenza Virus Vaccine Live, Intranasal (FluMist), to include the storage of FluMist vaccine for the current 2004-2005 influenza vaccination season in a conventional frost-free freezer without a "FreezeBox."

This acknowledgment recognizes that your submission is in the form of a "Prior Approval Supplement" as described under 21 CFR 601.12 (b)(1). This Supplement has been reviewed under STN 125020/43 and is approved effective this date.

This information will be included in your Biologics License Application file. It is recommended that a copy of this letter be available for review at the time of FDA inspections.

Sincerely yours,

--- signature ---

Jerry P. Weir, Ph.D.
Division of Viral Products
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research


Return to product page

Page Last Updated: 09/12/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English